The Impact of Nebivolol Versus Metoprolol on Quality of Life Measures and Cost-effectiveness in Stable Renal Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol succinate
- Indications Hypertension
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 14 Feb 2013 Planned End Date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 16 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.